EPO Patents = 4

Forward Citations = 16

Loading Chart...

9 inventors (with patents filed for the assignee):

Garth Cumberlidge (5 out of 5 patents)

Karen Meerovitch (5 out of 5 patents)

Teresa Lama (5 out of 5 patents)

4. Sébastien Rocchi (4 out of 4 patents)

5. Chantal Devin (4 out of 4 patents)

6. Wei Tian (4 out of 5 patents)

7. Martin Hans Bohlin (4 out of 29 patents)

8. Horacio Uri Saragovi (2 out of 8 patents)

9. Jeanick Pascal (1 out of 4 patents)

10. H Uri Saragovi (4 patents)

11. Uri H Saragovi (6 patents)

10 patents: Sort by Forward Citations

1. 12281179 - Solution phase synthesis of β-turn peptidomimetic cyclic salts (2025-04-21),

2. 11753441 - Solution phase synthesis of beta-turn peptidomimetic cyclic salts (2023-09-12),

3. 11078234 - Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts (2021-08-03),

4. 10125165 - Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts (2018-11-13),

5. 9707267 - Beta-turn peptidomimetic cyclic compounds for treating dry eye (2017-07-18),

6. 9156882 - Beta-turn peptidomimetic cyclic compounds for treating dry eye (2015-10-13),

7. 9115179 - Synthesis of beta-turn peptidomimetic cyclic compounds (2015-08-25),

8. 8748391 - β-turn peptidomimetic cyclic compounds for treating dry eye (2014-06-10),

9. 8653036 - Methods of treating retinitis pigmentosa (2014-02-18),

10. 8293713 - Beta-turn peptidomimetic cyclic compounds for treating dry eye (2012-10-23),

Company Overview

Mimetogen Pharmaceuticals, Inc. is a biotechnology company based in Montreal, Canada, focused on developing innovative therapies for ocular diseases. The company specializes in the research and development of novel drug candidates aimed at addressing unmet medical needs in the field of ophthalmology. Mimetogen's expertise lies in leveraging advanced drug delivery systems and pharmacological approaches to enhance patient outcomes and improve the quality of life for individuals suffering from various eye conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#108 in Montreal

#1,523 in Canada

#56,047 in the World

Montreal, Canada

Mimetogen Pharmaceuticals, Inc

Forward Citations = 16

9 inventors:

Garth Cumberlidge (5 out of 5 patents)

Karen Meerovitch (5 out of 5 patents)

Teresa Lama (5 out of 5 patents)

4. Sébastien Rocchi (4 out of 4 patents)

5. Chantal Devin (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mimetogen Pharmaceuticals, Inc. Retrieved from https://idiyas.com/company/mimetogen-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]